Project Grant 2423223

Award Date 7/15/25
Completion Date 6/30/28
Dollars Obligated $338K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Ames, IA 50011, USA
Similar Awards
This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $331,189 to develop a new, affordable technology for virus detection. The project integrates protein engineering and electrochemical biosensors to create a portable, room-temperature stable platform for virus testing in resource-limited environments. Key innovations include the use of stable enzymes that can be stored at ambient temperatures,...
The federal Project Grant award from the National Center for Advancing Translational Sciences (NCATS), part of the 93.350 CFDA program, will support the development of a novel biosensor for the detection of bacterial endotoxins. Through this $290,066 award, the awardee Monod Bio, Inc. will focus on (I) computational design and experimental selection of functional lipopolysaccharide (LPS) bioluminescent biosensors, (II) in vitro evolution of these biosensors to optimize sensitivity and stability,...
This Project Grant award of $305,000.00 from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a rapid point-of-care antimicrobial susceptibility testing (AST) kit. The goal is to create a microfluidic-based platform that can provide actionable AST results within 6-9 hours, compared to the current 3-5 day turnaround, to help physicians prescribe the optimal antibiotic dosage sooner. This will reduce...
This Project Grant awarded by the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $425,118 to Virginia Polytechnic Institute & State University (Virginia Tech) to develop a new portable biosensor capable of detecting known and emerging environmental toxins, including potential biowarfare agents, nanotechnology pollutants, and novel toxins. The key products to be delivered include a field-deployable biosensor that will...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...
This $933,796 Project Grant from the National Science Foundation's Division of Civil, Mechanical, and Manufacturing Innovation, under the Engineering program (CFDA 47.041), funds the development of paper-based biosensor test strips to detect soil contaminants such as arsenic and PFAS. Rensselaer Polytechnic Institute will engage citizen scientists and use bacteria as sensors to produce quantitative readings of contaminant concentrations in soil. Two types of bacteria - E. coli functioning as the...
This $450,000 Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) supports the development of an "In Vitro Biomanufacturing on a Chip (IBOC)" system at Iowa State University. The IBOC technology aims to enhance in vitro prototyping of biomanufacturing processes by providing rapid sensing feedback to optimize enzyme combinations and metabolic pathways. Key features include integrating photonic crystal biosensors and surface-enhanced Raman...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Macula Vision Systems Inc., a for-profit organization, supports the development of a novel microscopy platform to automate the interpretation of microbiology lab tests performed in hospitals. The project aims to address the shortage of trained lab technicians by engineering a specialized light source, customized camera, and AI-enabled algorithms to analyze...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award supports the development of a novel device that can rapidly and automatically extract pathogen DNA from whole blood samples to enable faster diagnosis of sepsis. The $274,858 award to New England Hemolytics, Inc., with a project period from September 1, 2024 to February 28, 2025, will fund the testing and optimization of this technology across common sepsis-causing pathogens. The...
The National Science Foundation (NSF), under its Engineering program (CFDA 47.041), awarded a $429,832 Project Grant to the University of Massachusetts (UMass) to develop a novel method for rapid and sensitive detection of nucleic acids such as DNA and RNA. The main objectives of the 5-year project are to: Determine the nanomechanoelectrical transduction principle of nucleic-acid nanostructures tethered to a graphene transistor and oscillating in an electric field. Achieve rapid,...

This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $337,632 to Iowa State University of Science and Technology to develop affordable and accurate tests for detecting bacterial endotoxins. The project aims to create artificial transcription factors (ATFs) as an alternative to the current reliance on horseshoe crab blood for this testing, which raises sustainability concerns. The key innovations include using droplet microfluidics and fluorescence polarization to identify high-affinity ATF variants, as well as integrating ATF-regulated gene circuits with paper substrates and portable instruments for cost-effective, field-deployable endotoxin detection. This research has the potential to transform endotoxin testing across multiple industries, including pharmaceuticals, medical devices, healthcare facilities, and environmental testing labs. The project will also involve mentoring undergraduates in commercializing research and developing a senior-level course on biomedical entrepreneurship.

Generated 8/5/25, 4:44 AM